HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Single Quantum Dot Imaging Reveals PKCβ-Dependent Alterations in Membrane Diffusion and Clustering of an Attention-Deficit Hyperactivity Disorder/Autism/Bipolar Disorder-Associated Dopamine Transporter Variant.

Abstract
The dopamine transporter (DAT) is a transmembrane protein that terminates dopamine signaling in the brain by driving rapid dopamine reuptake into presynaptic nerve terminals. Several lines of evidence indicate that DAT dysfunction is linked to neuropsychiatric disorders such as attention-deficit/hyperactivity disorder (ADHD), bipolar disorder (BPD), and autism spectrum disorder (ASD). Indeed, individuals with these disorders have been found to express the rare, functional DAT coding variant Val559, which confers anomalous dopamine efflux (ADE) in vitro and in vivo. To elucidate the impact of the DAT Val559 variant on membrane diffusion dynamics, we implemented our antagonist-conjugated quantum dot (QD) labeling approach to monitor the lateral mobility of single particle-labeled transporters in transfected HEK-293 and SK-N-MC cells. Our results demonstrate significantly higher diffusion coefficients of DAT Val559 compared to those of DAT Ala559, effects likely determined by elevated N-terminal transporter phosphorylation. We also provide pharmacological evidence that PKCβ-mediated signaling supports enhanced DAT Val559 membrane diffusion rates. Additionally, our results are complimented with diffusion rates of phosphomimicked and phosphorylation-occluded DAT variants. Furthermore, we show DAT Val559 has a lower propensity for membrane clustering, which may be caused by a mutation-derived shift out of membrane microdomains leading to faster lateral membrane diffusion rates. These findings further demonstrate a functional impact of DAT Val559 and suggest that changes in transporter localization and lateral mobility may sustain ADE and contribute to alterations in dopamine signaling underlying multiple neuropsychiatric disorders.
AuthorsLucas B Thal, Ian D Tomlinson, Meagan A Quinlan, Oleg Kovtun, Randy D Blakely, Sandra J Rosenthal
JournalACS chemical neuroscience (ACS Chem Neurosci) Vol. 10 Issue 1 Pg. 460-471 (01 16 2019) ISSN: 1948-7193 [Electronic] United States
PMID30153408 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Dopamine Plasma Membrane Transport Proteins
  • PRKCB protein, human
  • Protein Kinase C beta
  • Valine
Topics
  • Attention Deficit Disorder with Hyperactivity (genetics, metabolism)
  • Autistic Disorder (genetics, metabolism)
  • Bipolar Disorder (genetics, metabolism)
  • Cell Membrane (genetics, metabolism)
  • Diffusion
  • Dopamine Plasma Membrane Transport Proteins (genetics, metabolism)
  • Genetic Variation (physiology)
  • HEK293 Cells
  • Humans
  • Protein Kinase C beta (genetics, metabolism)
  • Quantum Dots (metabolism)
  • Valine (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: